SCHEMBL6762003

SCHEMBL6762003

C#CC1(C#C)C2CC3CC(C2)CC1(c1ccccc1C#Cc1ccccc1)C3

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.33
KDM4E B2RXH2 2/20 0.33
MEN1 O00255 2/20 0.33
MAPT P10636 2/20 0.33
KMT2A Q03164 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
HPGD P15428 1/20 0.33
CYP2C19 P33261 1/20 0.33
HSD17B10 Q99714 1/20 0.33
RAB9A P51151 2/20 0.33
HSD11B1 P28845 4/20 0.32
FFAR1 O14842 2/20 0.31
APP P05067 1/20 0.31
LMNA P02545 1/20 0.30
CASP3 P42574 1/20 0.30
SENP7 Q9BQF6 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2319389 0.78 MAPT (0.39) NPC1KDM4EMEN1MAPTKMT2A
SCHEMBL6762051 0.77 HSD11B1 (0.33) MEN1KMT2AHSD11B1
SCHEMBL6767079 0.77 HSD11B1 (0.41) KDM4EMEN1KMT2AHSD11B1P2RX7
SCHEMBL6764307 0.76 NPC1 (0.35) NPC1KDM4EMEN1MAPTKMT2A
SCHEMBL6683930 0.76 ALDH1A1 (0.42) NPC1KDM4EMEN1MAPTKMT2A
SCHEMBL6762049 0.72 NPC1 (0.33) NPC1KDM4EMEN1MAPTKMT2A
SCHEMBL6765059 0.71 HSD11B1 (0.36) MEN1KMT2AHSD11B1APPP2RX7
SCHEMBL6764233 0.70 P2RX7 (0.30) P2RX7
SCHEMBL6765056 0.69 ALDH1A1 (0.38) NPC1KDM4EMEN1MAPTKMT2A
SCHEMBL5898842 0.68 NPC1 (0.35) NPC1KDM4EMEN1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040127715-A1 Adamantane compounds and insulating film forming coating solutions SUMITOMO CHEMICAL COMPANY, LIMITED 2004-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040127715-A1 Adamantane compounds and insulating film forming coating solutions CHRNA1, ANO1, CHRNA2 NPC1 696/4885KDM4E 1921/4885MEN1 521/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.